A new trading day began on May 19, 2023, with Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock priced at $0.6615, up 2.73% from the previous day of trading. During the day, the shares moved up to $0.685 and dropped to $0.6521 before settling in for the closing price of $0.65. INO’s price has ranged from $0.64 to $2.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -24.60%. Meanwhile, its annual earnings per share averaged 19.40%. With a float of $245.68 million, this company’s outstanding shares have now reached $258.44 million.
Let’s determine the extent of company efficiency that accounts for 184 employees. In terms of profitability, gross margin is +46.44, operating margin of -2672.64, and the pretax margin is -2705.57.
Inovio Pharmaceuticals Inc. (INO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc. is 0.40%, while institutional ownership is 47.80%. The most recent insider transaction that took place on Mar 13, was worth 6,708. In this transaction Director of this company sold 5,833 shares at a rate of $1.15, taking the stock ownership to the 910,124 shares. Before that another transaction happened on Feb 27, when Company’s Director sold 11,668 for $1.28, making the entire transaction worth $14,935. This insider now owns 904,291 shares in total.
Inovio Pharmaceuticals Inc. (INO) Earnings and Forecasts
In its latest quarterly report, released on 3/30/2023, the company reported earnings of -$0.16 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -2726.67 while generating a return on equity of -89.97. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.50% during the next five years compared to -1.70% drop over the previous five years of trading.
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Trading Performance Indicators
Here are Inovio Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc. (INO)
Looking closely at Inovio Pharmaceuticals Inc. (NASDAQ: INO), its last 5-days average volume was 9.53 million, which is a jump from its year-to-date volume of 5.27 million. As of the previous 9 days, the stock’s Stochastic %D was 15.15%. Additionally, its Average True Range was 0.07.
During the past 100 days, Inovio Pharmaceuticals Inc.’s (INO) raw stochastic average was set at 2.08%, which indicates a significant decrease from 12.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.87% in the past 14 days, which was lower than the 83.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8590, while its 200-day Moving Average is $1.6180. However, in the short run, Inovio Pharmaceuticals Inc.’s stock first resistance to watch stands at $0.6860. Second resistance stands at $0.7020. The third major resistance level sits at $0.7189. If the price goes on to break the first support level at $0.6531, it is likely to go to the next support level at $0.6362. Should the price break the second support level, the third support level stands at $0.6202.
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Key Stats
With a market capitalization of 171.42 million, the company has a total of 262,740K Shares Outstanding. Currently, annual sales are 10,260 K while annual income is -279,820 K. The company’s previous quarter sales were 110 K while its latest quarter income was -40,650 K.
